While bringing this to everyone's attention it's probably also prudent to call out that this is a generic accounting paragraph in any annual report for any company who is not in a commercial phase and who will require imminent capital to be raised to continue operation until a positive revenue stream is established.
It's required to cover the accounting firm's arse.
it, or words similar will be in the financials of every listed biotech startup still in development.
GLTAH.
Where is IBX headed, page-7
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
